Synopsis: A sugar-lipid molecule called OAcGD2 is a novel marker for breast cancer stem cells. Treatment with anti-OAcGD2 mAb8B6 may have superior anticancer efficacy by targeting cancer stem cells, ...

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.

Our objective was to culture these cells in order to understand them and exploit their therapeutic potential to the full. Design Here, hypothesising that some CTC potentially have cancer stem cell ...

Mechanical factors influence the initial fate of cancer cells after they have left a primary tumour. Blood-flow patterns from the primary tumour determine which organ the cells travel to first.

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

While neither inhibitor has been examined in clinical trials against any cancer type, Kim et al. demonstrated that eptifibatide significantly reduced the ability of B16-F10 melanoma cells to form ...

Feb. 3, 2025 — Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune ... Study Establishes Link ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

It’s impossible to get someone off your mind as Venus and Pluto harmonize. Put yourself out there! They’ll appreciate your public gesture but won’t make one of their own. The mystery has you ...

Research breakthroughs are giving patients with atopic dermatitis/eczema more ways to treat this condition. See what a treatment plan may include.

“ID3+ T cells have the remarkable ability to resist burnout and maintain a powerful immune response over time, making them particularly effective in the face of chronic infections or cancer ...